Network Accelerate Scheme

The Network Accelerate Scheme provides funds (to a maximum of £250,000) for research resources or tools that could be of benefit to biomedical dementia research in the Alzheimer’s Research UK Network and beyond, as well as shared within the Alzheimer’s Research UK Network.

This could include the generation and validation of reagents, such as antibodies or tool compounds, the maintenance/creation of research resources (sample collections, data analysis/bioinformatics tools) or scientific networking beyond what could normally be covered by contributions from Network Centre grants. Examples of these could be topic-specific meetings or groupings (e.g. covering a specific dementia subtype, methodology, area of interest).

Provides up to £250,000 to cover salaries (research, technical, students etc), equipment, animal costs and running costs (consumables, travel etc).

Apply now

Application FAQs

The Lead Applicant and point of contact must be a member of the Alzheimer’s Research UK Network.

A Network Resource Grant must include two or more Alzheimer’s Research UK Network Centres. It can also include researchers or institutions outside the UK.

The Lead Applicant is expected to have a contract (fixed term or tenure) which covers the proposed duration of the grant. If the Lead Applicant does not hold a tenure appointment, the application must include a co-applicant that does.

If the project requires Ethics approval and/or Home Office licences, the award is dependent upon the requisite approvals being granted.

This scheme is not designed to cover:
•Clinical trials and opportunities to research ‘add ons’ to ongoing clinical trials
•Drug discovery or development

 

Clinical trials and add-ons should be applied for through the Global Clinical Trials Fund. Drug discovery and development work should be applied for through the Dementia Consortium or through ARUK’s Drug Discovery Institutes.

Applications are made via our grant application website.

Grant schemes only appear on this website when the round is open and we are accepting new applications.

View an example Network Acceleration Scheme application form.

Alzheimer’s Research UK is a member of the Association of Medical Research Charities and follows their guidelines for best practice in peer review. Grants are awarded entirely on scientific merit in relation to Alzheimer’s Research UK’s remit and on the basis of open competition. The quality of the application and applicants is the key determinant of outcome, although the strength of the dementia research environment within the institution is also considered.

External review

Applications requesting funding of over £50,000 per year are subjected to external peer review. Applications are sent to researchers in the UK and worldwide who specialise in the area of the application, but who do not have a conflict of interest and are not a member of the SAB. The comments made by the external reviewers are made available to the SAB members.

Discussion in meeting

Each application is allocated to two Grant Review Board (GRB) members, based roughly on their areas of expertise. The two members will present the application to the rest of the board, including any relevant information from external reviews or applicant responses. A short discussion will follow before the GRB score the application. Applications for each grant scheme are ranked by their average score and recommendations for funding are made.

Trustee meeting

Those applications recommended for funding by the GRB are presented to the trustees for final approval.

The terms and conditions of grant differ for each grant scheme and contracts are drawn up individually once the grants have been awarded.

Monitoring

All grant holders are expected to report on the progress of their project on a regular basis. Read more about our reporting requirements on the measuring impact page.

For more information about any of the grant schemes or the application process please contact the Research Team research@alzheimersresearchuk.org or 0300 111 5555.

Up to £250,000

Provides funds for research resources or tools to benefit the biomedical dementia research field.

Key Dates

  • 23/01/2019
    Applicants will be notified of the response early July 2019
  • 03/07/2019
    Applicants will be notified of the response early January 2020